Creative Medical Technology to Participate in the 34th Annual Roth Conference

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that Company executives will be participating in the 34^th Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. Management will be available for one-on-one meetings throughout the conference.

A copy of the Company`s latest investor presentation, which will be used during one-on-one meetings, can be found on Creative Medical Technology`s IR website at: https://creativemedicaltechnology.investorroom.com/.

About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of immunotherapy, urology, neurology, and orthopedics.

About Roth Capital Partners
Roth Capital Partners, LLC ("Roth") is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services, and corporate access. Headquartered in Newport Beach, California, Roth is privately held and owned by its employees and maintains offices throughout the U.S.